What is the current stock price of Mayne Pharma Group Limited (MAYNF)?

As of the latest market data, Mayne Pharma Group Limited (MAYNF) is trading at $1.76. The stock has seen a loss of 0.00% today.

Does Mayne Pharma Group Limited (MAYNF) pay a dividend?

Based on current data, Mayne Pharma Group Limited does not have a confirmed active dividend policy.

What is the market cap of Mayne Pharma Group Limited?

The current market capitalization of Mayne Pharma Group Limited (MAYNF) is approximately unavailable.

MAYNF

Mayne Pharma Group Limited·Healthcare

1.76

0.000%(+0.00)

Market Closed

1.77

0.568%(+0.01)

After Hours

Last Updated: — ET

52W L: $1.6352W H: $4.27

MAYNF NEWS

defenseworld.net

Mar 14

Contrasting Otsuka (OTCMKTS:OTSKY) and Mayne Pharma Group (OTCMKTS:MAYNF)

Mayne Pharma Group (OTCMKTS:MAYNF - Get Free Report) and Otsuka (OTCMKTS:OTSKY - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership. Analyst Recommendations This is a summary of recent

seekingalpha.com

Mar 11

Mayne Pharma Group Limited (MAYNF) Discusses U.S. Launch and Business Model of DistributeRx Transcript

seekingalpha.com

Feb 22

Mayne Pharma Group Limited (MAYNF) Q2 2026 Earnings Call Transcript

defenseworld.net

Feb 20

Mayne Pharma Group (OTCMKTS:MAYNF) Stock Price Up 1.4% – Should You Buy?

Mayne Pharma Group Limited (OTCMKTS:MAYNF - Get Free Report)'s stock price was up 1.4% on Thursday. The stock traded as high as $1.8550 and last traded at $1.8550. Approximately 731 shares were traded during mid-day trading, a decline of 87% from the average daily volume of 5,454 shares. The stock had previously closed at

seekingalpha.com

Jan 28

Mayne Pharma Group Limited (MAYNF) Shareholder/Analyst Call Transcript

Company Profile

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

450

IPO Date

2013-03-22

Beta

0.96

Websitewww.maynepharma.com↗